Cargando…
A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines
BACKGROUND: We previously reported the anti-estrogenic activity of the brown seaweed, Fucus vesiculosus. The present study aimed to further investigate its anti-estrogenic modes of action and to assess other potentially biologically relevant anti-tumorigenic effects in estrogen receptor (ER)-depende...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884380/ https://www.ncbi.nlm.nih.gov/pubmed/27234961 http://dx.doi.org/10.1186/s12906-016-1129-6 |
_version_ | 1782434364870623232 |
---|---|
author | Zhang, Jianqing Riby, Jacques E. Conde, Lucia Grizzle, William E. Cui, Xiangqin Skibola, Christine F. |
author_facet | Zhang, Jianqing Riby, Jacques E. Conde, Lucia Grizzle, William E. Cui, Xiangqin Skibola, Christine F. |
author_sort | Zhang, Jianqing |
collection | PubMed |
description | BACKGROUND: We previously reported the anti-estrogenic activity of the brown seaweed, Fucus vesiculosus. The present study aimed to further investigate its anti-estrogenic modes of action and to assess other potentially biologically relevant anti-tumorigenic effects in estrogen receptor (ER)-dependent and -independent female cancer cell lines. METHODS: The CALUX® assay was used to determine the effect of a F. vesiculosus extract (FVE) on activation of the ER. Aromatase enzymatic activity was measured to determine the potential effect of FVE on estradiol (E2) biosynthesis. Transcriptional activity profiling of 248 genes involved in cancer, immunity, hormonal regulation, protein phosphorylation, transcription, metabolism, and cellular structure was conducted using the NanoString nCounter® analysis system in FVE-treated breast, ovarian and endometrial cancer cell lines. The effects of FVE on cell viability, morphology, membrane integrity, mitochondrial toxicity, induction of apoptotic and autophagic markers, and cell signaling were also analyzed. RESULTS: In co-treatments with 12.5 pM (EC(50)) E2, FVE (2 %) reduced ER activation by 50 %, exhibiting potent ER antagonistic effects. FVE inhibited aromatase activity in an in vitro assay (IC(50) 2.0 %). ER-dependent and -independent cancer cell lines showed significantly decreased viability that correlated with increasing FVE concentrations and altered morphological features suggestive of apoptosis and autophagy. Expression of genes that were significantly altered by FVE (p < 0.05) revealed predominantly apoptotic, autophagic and kinase signaling pathways. FVE also effectively inhibited the phosphorylation of Akt, resulting in reduced mTORC1 activities to stimulate autophagy in cells. Concentration-dependent cleavage of PARP and induction of caspase-3 and -7 activities were observed in MDA-MB-231 cells supporting a role for FVE in the promotion of apoptosis. CONCLUSIONS: Our study provides new insights into the anti-estrogenic activity of F. vesiculosus. Moreover, the induction of autophagy and apoptosis on breast, endometrial and ovarian cancer cell lines suggests additional anti-tumorigenic actions of FVE that are independent of ER status in female cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1129-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4884380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48843802016-05-29 A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines Zhang, Jianqing Riby, Jacques E. Conde, Lucia Grizzle, William E. Cui, Xiangqin Skibola, Christine F. BMC Complement Altern Med Research Article BACKGROUND: We previously reported the anti-estrogenic activity of the brown seaweed, Fucus vesiculosus. The present study aimed to further investigate its anti-estrogenic modes of action and to assess other potentially biologically relevant anti-tumorigenic effects in estrogen receptor (ER)-dependent and -independent female cancer cell lines. METHODS: The CALUX® assay was used to determine the effect of a F. vesiculosus extract (FVE) on activation of the ER. Aromatase enzymatic activity was measured to determine the potential effect of FVE on estradiol (E2) biosynthesis. Transcriptional activity profiling of 248 genes involved in cancer, immunity, hormonal regulation, protein phosphorylation, transcription, metabolism, and cellular structure was conducted using the NanoString nCounter® analysis system in FVE-treated breast, ovarian and endometrial cancer cell lines. The effects of FVE on cell viability, morphology, membrane integrity, mitochondrial toxicity, induction of apoptotic and autophagic markers, and cell signaling were also analyzed. RESULTS: In co-treatments with 12.5 pM (EC(50)) E2, FVE (2 %) reduced ER activation by 50 %, exhibiting potent ER antagonistic effects. FVE inhibited aromatase activity in an in vitro assay (IC(50) 2.0 %). ER-dependent and -independent cancer cell lines showed significantly decreased viability that correlated with increasing FVE concentrations and altered morphological features suggestive of apoptosis and autophagy. Expression of genes that were significantly altered by FVE (p < 0.05) revealed predominantly apoptotic, autophagic and kinase signaling pathways. FVE also effectively inhibited the phosphorylation of Akt, resulting in reduced mTORC1 activities to stimulate autophagy in cells. Concentration-dependent cleavage of PARP and induction of caspase-3 and -7 activities were observed in MDA-MB-231 cells supporting a role for FVE in the promotion of apoptosis. CONCLUSIONS: Our study provides new insights into the anti-estrogenic activity of F. vesiculosus. Moreover, the induction of autophagy and apoptosis on breast, endometrial and ovarian cancer cell lines suggests additional anti-tumorigenic actions of FVE that are independent of ER status in female cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1129-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-28 /pmc/articles/PMC4884380/ /pubmed/27234961 http://dx.doi.org/10.1186/s12906-016-1129-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhang, Jianqing Riby, Jacques E. Conde, Lucia Grizzle, William E. Cui, Xiangqin Skibola, Christine F. A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title | A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title_full | A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title_fullStr | A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title_full_unstemmed | A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title_short | A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
title_sort | fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884380/ https://www.ncbi.nlm.nih.gov/pubmed/27234961 http://dx.doi.org/10.1186/s12906-016-1129-6 |
work_keys_str_mv | AT zhangjianqing afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT ribyjacquese afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT condelucia afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT grizzlewilliame afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT cuixiangqin afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT skibolachristinef afucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT zhangjianqing fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT ribyjacquese fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT condelucia fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT grizzlewilliame fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT cuixiangqin fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines AT skibolachristinef fucusvesiculosusextractinhibitsestrogenreceptoractivationandinducescelldeathinfemalecancercelllines |